Detrimental Impact of Chemotherapy Dose Reduction or Discontinuation in Early Stage Triple-Negative Breast Cancer Treated With Pembrolizumab and Neoadjuvant Chemotherapy: A Multicenter Experience.
Krishnan J, Patel A, Roy AM, Alharbi M, Kapoor A, Yao S, Khoury T, Hong CC, Held N, Chakraborty A, Kaliniski P, Salman A, Catalfamo K, Attwood K, Kirtani V, Shaikh SS, Chaudhary LN, Gandhi S.
Krishnan J, et al. Among authors: chakraborty a.
Clin Breast Cancer. 2024 Aug 6:S1526-8209(24)00217-9. doi: 10.1016/j.clbc.2024.08.005. Online ahead of print.
Clin Breast Cancer. 2024.
PMID: 39198116
Free article.